Gilead stock climbs 5% as investors bet company is in a trough, not a plateau By: MarketWatch February 07, 2018 at 12:25 PM EST Wall Street has described 2018 as the company’s ‘trough’ year as other product sales replace falling hepatitis C revenue. Read More >> Related Stocks: Gilead Sciences
